A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. / Luo, Yunyun; He, Y; Byrjalsen, I; Henriksen, K; Gudmann, N S; Mobasheri, A; Hansen, G; Karsdala, M; Bay-Jensen, A-C.
In:
Osteoarthritis and Cartilage, Vol. 25, No. Suplement 1, 2017, p. S106-S107.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review